[go: up one dir, main page]

CN116585219A - A kind of eye care composition for alleviating asthenopia and preparation method thereof - Google Patents

A kind of eye care composition for alleviating asthenopia and preparation method thereof Download PDF

Info

Publication number
CN116585219A
CN116585219A CN202310401408.9A CN202310401408A CN116585219A CN 116585219 A CN116585219 A CN 116585219A CN 202310401408 A CN202310401408 A CN 202310401408A CN 116585219 A CN116585219 A CN 116585219A
Authority
CN
China
Prior art keywords
care composition
eye care
preparation
deionized water
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202310401408.9A
Other languages
Chinese (zh)
Inventor
郄昆才
李婷
王炤方
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Weifang Nursing Vocational College
Original Assignee
Weifang Nursing Vocational College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Weifang Nursing Vocational College filed Critical Weifang Nursing Vocational College
Priority to CN202310401408.9A priority Critical patent/CN116585219A/en
Publication of CN116585219A publication Critical patent/CN116585219A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention provides an eye care composition for relieving asthenopia and a preparation method thereof, and belongs to the field of eye care compositions. The eye care composition for relieving asthenopia and the preparation method thereof comprise the following steps: pretreatment, preparation of active hydrogels, preparation of eye care compositions. The eye care composition has small irritation to eyes and skin, has no toxic or side effect, and effectively avoids the irritation of components such as functional substances, preservatives and the like to eyes and skin and the discomfort of eyes or skin possibly occurring in long-term use; the effective components of the eye care composition are easy to absorb, and can effectively relieve visual fatigue; and further improves the long-term storage stability of the eye care composition.

Description

一种缓解视疲劳的眼部护理组合物及其制备方法A kind of eye care composition for alleviating asthenopia and preparation method thereof

技术领域technical field

本发明涉及眼部护理组合物领域,尤其是涉及一种缓解视疲劳的眼部护理组合物及其制备方法。The invention relates to the field of eye care compositions, in particular to an eye care composition for relieving visual fatigue and a preparation method thereof.

背景技术Background technique

视疲劳综合征是眼睛在长时间超负荷工作之后出现的一种持续衰弱状态,其临床表现主要有眼酸、眼胀、眼干、流泪、视物模糊等,属心身医学范畴。近年来由于社会环境变化、电子产品普及、工作节奏加快、屈光不正人群增加等原因,超负荷用眼的情况越来越多,视疲劳发病趋势逐年上升。Asthenopia Syndrome is a state of continuous weakness of the eyes after long-term overload work. Its clinical manifestations mainly include eye soreness, eye swelling, dry eyes, tearing, and blurred vision. It belongs to the category of psychosomatic medicine. In recent years, due to changes in the social environment, the popularization of electronic products, the accelerated pace of work, and the increase in the number of people with refractive errors, there have been more and more cases of overloading the eyes, and the incidence of visual fatigue has increased year by year.

随着科技的进步,电子产品的类型越来越多,电子产品不仅作为娱乐工具,更多的是作为工作、学习和生活必不可少的工具而存在。因此,人们使用电子设备的时间也越来越长,由此需要承担过度的用眼负荷,进而产生视疲劳的相关症状。目前公认能够缓解视疲劳、屈光不正的局部保健方法,大多患者因工作或学习原因无法使眼睛得到充分休息,而难以缓解相关症状。With the advancement of technology, there are more and more types of electronic products. Electronic products not only serve as entertainment tools, but also exist as indispensable tools for work, study and life. Therefore, people spend more and more time using electronic devices, so they need to bear excessive eye load, and then produce related symptoms of visual fatigue. At present, it is recognized that local health care methods can relieve visual fatigue and refractive errors. Most patients cannot get enough rest for their eyes due to work or study, and it is difficult to relieve related symptoms.

因此,视疲劳的症状复杂多变,其症状出现的轻重与个人性格、心理状态、生活及工作环境有着密切的联系。目前,对于视疲劳的治疗,主要为矫正屈光不正、矫正眼位、调节功能训练,以及药物治疗。但手术治疗、棱镜矫正、功能训练等方法虽然疗效较好,但使用范围窄,无法适用于绝大多数的视疲劳患者;而药物治疗不仅有一定的毒副作用,还可能会形成药物依赖。现代人在承受巨大工作、生活压力的同时,难以避免超负荷用眼,也难以对日常作息时间进行有效调整,也导致一些较为有效的视疲劳预防措施在实际工作及生活中难以有效执行。Therefore, the symptoms of visual fatigue are complex and changeable, and the severity of symptoms is closely related to personal personality, psychological state, living and working environment. At present, the treatment of asthenopia mainly includes correction of refractive error, correction of eye position, adjustment function training, and drug therapy. However, although surgical treatment, prism correction, functional training and other methods have good curative effects, they are limited in scope and cannot be applied to the vast majority of visual fatigue patients; and drug treatment not only has certain toxic and side effects, but may also cause drug dependence. While modern people are under tremendous work and life pressure, it is difficult to avoid overloading the eyes, and it is also difficult to effectively adjust the daily work and rest time, which also makes it difficult to effectively implement some effective preventive measures for visual fatigue in actual work and life.

为对眼部进行护理,缓解视疲劳,现有技术中有眼部护理液、人工泪液及洗眼液等产品。其中,人工泪液为模拟眼泪的生理盐水,无其他添加剂,但其对于眼部的护理性能及视疲劳的缓解能力有限。洗眼液和眼部护理液,通常是采用纯化水或蒸馏水与功能性物质、助剂等成分复配;通过滴加至眼睑内,或涂覆于眼皮上,实现对眼部的护理功能,进而一定程度上缓解视疲劳。但是,发明人经研究发现,现有的眼部护理组合物中添加的功能性物质、防腐剂等成分,对眼睛及皮肤有一定的刺激性,长期使用可能会出现眼睛及皮肤的充血、发痒、红肿等副作用。同时,眼部护理组合物涂覆于眼皮后,有效成分不易被皮肤吸收,易吸收性有待进一步提高。并且,现有的眼部护理组合物开封后,稳定储存时间较短,活性成分易于失效,长期储存稳定性有待进一步提高。For eye care, relieve visual fatigue, products such as eye care solution, artificial tears and eyewash are arranged in the prior art. Among them, artificial tears are physiological saline that simulates tears without other additives, but their ability to relieve eye care and visual fatigue is limited. Eyewash and eye care solutions are usually compounded with purified water or distilled water and functional substances, additives and other ingredients; by dripping into the eyelids or coating on the eyelids, the eye care function is realized, and then Relieve visual fatigue to a certain extent. However, the inventor has found through research that the functional substances, preservatives and other components added in the existing eye care composition have certain irritation to the eyes and skin, and long-term use may cause hyperemia and hair loss of the eyes and skin. Itching, redness and other side effects. At the same time, after the eye care composition is applied to the eyelids, the active ingredients are not easily absorbed by the skin, and the absorbability needs to be further improved. Moreover, after the existing eye care composition is opened, the stable storage time is relatively short, the active ingredients are prone to failure, and the long-term storage stability needs to be further improved.

发明内容Contents of the invention

为解决现有技术中存在的技术问题,本发明提供一种缓解视疲劳的眼部护理组合物及其制备方法,对眼睛及皮肤刺激性小,无毒副作用,有效避免功能性物质、防腐剂等成分对眼睛、皮肤的刺激,以及长期使用可能出现的眼睛或皮肤不适;眼部护理组合物的有效成分易吸收,能够有效缓解视疲劳;进一步提高眼部护理组合物的长期储存稳定性。In order to solve the technical problems existing in the prior art, the present invention provides an eye care composition for relieving visual fatigue and a preparation method thereof, which is less irritating to eyes and skin, has no toxic and side effects, and effectively avoids functional substances and preservatives The ingredients such as eye and skin irritation, and eye or skin discomfort that may occur after long-term use; the active ingredients of the eye care composition are easy to absorb, and can effectively relieve visual fatigue; further improve the long-term storage stability of the eye care composition.

为解决以上技术问题,本发明采取的技术方案如下:For solving above technical problem, the technical scheme that the present invention takes is as follows:

一种缓解视疲劳的眼部护理组合物的制备方法,由以下步骤组成:预处理、制备活性水凝胶、制备眼部护理组合物。A method for preparing an eye care composition for relieving visual fatigue, comprising the following steps: pretreatment, preparation of active hydrogel, and preparation of an eye care composition.

所述预处理,将透明质酸钠投入至95-100倍重量份的去离子水中,分散均匀,降温至2-5℃,保温静置4-6h;调节pH值至8-8.5,保持温度为2-5℃,搅拌20-30min;然后投入甲基丙烯酸酐,在2-5℃温度条件下,保温处理10-12h,获得预处理液;将预处理液投入至3-5倍体积的无水乙醇中,至无沉淀析出,滤出固体物;固体物经8-10倍体积的无水乙醇洗涤后,投入至75-85倍重量份的去离子水中,搅拌均匀后,经透析处理,制得预处理物。In the pretreatment, put sodium hyaluronate into 95-100 times the weight of deionized water, disperse evenly, cool down to 2-5°C, and keep it for 4-6h; adjust the pH value to 8-8.5, and keep the temperature Stir at 2-5°C for 20-30min; then put in methacrylic anhydride, and keep warm for 10-12h at a temperature of 2-5°C to obtain a pretreatment liquid; put the pretreatment liquid into 3-5 times the volume In dehydrated ethanol, until there is no precipitation, filter out the solid matter; after the solid matter is washed with 8-10 times the volume of dehydrated ethanol, it is put into 75-85 times the weight of deionized water, and after being stirred evenly, it is treated by dialysis , to obtain a pretreatment.

所述预处理中,透明质酸钠与甲基丙烯酸酐的重量份比值为1:2.5-3。In the pretreatment, the weight ratio of sodium hyaluronate to methacrylic anhydride is 1:2.5-3.

所述预处理中,透析处理过程中截留分子量为10-12KDa,透析处理时间为20-24h。In the pretreatment, the molecular weight cut-off during the dialysis treatment is 10-12KDa, and the dialysis treatment time is 20-24h.

所述制备活性水凝胶,将活性成分投入至去离子水中,搅拌20-40min;然后投入预处理物、N-异丙基丙烯酰胺,继续搅拌20-30min;在氮气气氛环境下,100-200rpm搅拌条件下,升温至30-35℃,投入过硫酸铵,保温搅拌1-3h,制得活性水凝胶。To prepare the active hydrogel, put the active ingredient into deionized water and stir for 20-40 minutes; then put in the pretreated product, N-isopropylacrylamide, and continue stirring for 20-30 minutes; in a nitrogen atmosphere, 100- Under the condition of stirring at 200rpm, the temperature is raised to 30-35°C, ammonium persulfate is added, and the mixture is kept stirring for 1-3 hours to prepare the active hydrogel.

所述制备活性水凝胶中,预处理物、N-异丙基丙烯酰胺、活性成分、过硫酸铵、去离子水的重量份比值为30-35:70-75:7-9:0.5-0.6:1000-1200。In the preparation of the active hydrogel, the weight ratio of the pretreatment, N-isopropylacrylamide, active ingredient, ammonium persulfate, and deionized water is 30-35:70-75:7-9:0.5- 0.6:1000-1200.

所述制备活性水凝胶中,活性成分由以下成分组成:罗汉果提取物、红薯叶提取物、蓝莓提取物;优选的,罗汉果提取物、红薯叶提取物、蓝莓提取物的重量份比值为12-15:8-10:3-5。In the preparation of the active hydrogel, the active ingredient is composed of the following ingredients: Luo Han Guo extract, sweet potato leaf extract, and blueberry extract; preferably, the weight ratio of Luo Han Guo extract, sweet potato leaf extract, and blueberry extract is 12 -15:8-10:3-5.

优选的,罗汉果提取物的规格为80-100目,提取比例为10-20:1;Preferably, the specification of Luo Han Guo extract is 80-100 mesh, and the extraction ratio is 10-20:1;

红薯叶提取物的规格为80-100目,提取比例为10-20:1;The specification of sweet potato leaf extract is 80-100 mesh, and the extraction ratio is 10-20:1;

蓝莓提取物的规格为80-100目,提取比例为10-20:1。The specification of blueberry extract is 80-100 mesh, and the extraction ratio is 10-20:1.

所述制备眼部护理组合物,将乙二胺四乙酸二钠、卡波姆、水解胶原蛋白、甘油投入至灭菌后的去离子水中,分散均匀后,继续投入活性水凝胶、1,2-戊二醇、甘油硬脂酸酯、霍霍巴油、L-丝氨酸、维生素E、生育酚乙酸酯、十八醇,混合均匀,制得缓解视疲劳的眼部护理组合物。To prepare the eye care composition, put disodium edetate, carbomer, hydrolyzed collagen, and glycerin into sterilized deionized water, and after dispersing evenly, continue to put in active hydrogel, 1, 2-pentanediol, glyceryl stearate, jojoba oil, L-serine, vitamin E, tocopheryl acetate and stearyl alcohol are uniformly mixed to prepare an eye care composition for relieving visual fatigue.

所述制备眼部护理组合物中,去离子水、乙二胺四乙酸二钠、卡波姆、水解胶原蛋白、甘油、活性水凝胶、1,2-戊二醇、甘油硬脂酸酯、霍霍巴油、L-丝氨酸、维生素E、生育酚乙酸酯、十八醇的重量份比值为40-45:0.15-0.2:0.5-0.6:2-3:4-5:40-45:6-7:2-3:0.8-1:1.5-2:0.15-0.2:0.05-0.06:0.8-1。In the preparation of the eye care composition, deionized water, disodium edetate, carbomer, hydrolyzed collagen, glycerin, active hydrogel, 1,2-pentanediol, glyceryl stearate , jojoba oil, L-serine, vitamin E, tocopheryl acetate, stearyl alcohol in parts by weight ratio of 40-45:0.15-0.2:0.5-0.6:2-3:4-5:40-45: 6-7:2-3:0.8-1:1.5-2:0.15-0.2:0.05-0.06:0.8-1.

一种缓解视疲劳的眼部护理组合物,采用前述的制备方法制得。An eye care composition for relieving asthenopia, prepared by the aforementioned preparation method.

与现有技术相比,本发明的有益效果为:Compared with prior art, the beneficial effect of the present invention is:

(1)本发明的缓解视疲劳的眼部护理组合物的制备方法,缓解视疲劳的眼部护理组合物,通过采用甲基丙烯酸酐对透明质酸钠进行预处理;并采用预处理物、N-异丙基丙烯酰胺、活性成分用于制备活性水凝胶步骤中;将活性水凝胶与其他特定原料相配合,制得缓解视疲劳的眼部护理组合物,对眼睛及皮肤的刺激性小,无毒副作用,有效避免功能性物质、防腐剂等成分对眼睛、皮肤的刺激,以及长期使用可能出现的眼睛或皮肤不适;眼部护理组合物的有效成分易吸收,能够有效缓解视疲劳;并进一步提高眼部护理组合物的长期储存稳定性。(1) The preparation method of the eye care composition for relieving visual fatigue of the present invention, the eye care composition for relieving visual fatigue, pretreats sodium hyaluronate by using methacrylic anhydride; and uses the pretreatment, N-isopropylacrylamide and active ingredients are used in the step of preparing active hydrogel; the active hydrogel is combined with other specific raw materials to prepare an eye care composition for relieving visual fatigue and irritation to eyes and skin It has low toxicity, no toxic and side effects, and can effectively avoid eye and skin irritation by functional substances, preservatives and other ingredients, as well as eye or skin discomfort that may occur after long-term use; the active ingredients of the eye care composition are easy to absorb, and can effectively relieve vision loss. fatigue; and further improve long-term storage stability of eye care compositions.

(2)本发明的缓解视疲劳的眼部护理组合物,经化妆品致敏试验,试验动物的皮肤无红斑和焦痂形成,无水肿,致敏率为0%,对皮肤刺无刺激,有效避免功能性物质、防腐剂等成分对眼睛、皮肤的刺激,以及长期使用可能出现的眼睛及皮肤不适。(2) The eye care composition for relieving visual fatigue of the present invention, through the cosmetic sensitization test, the skin of the test animal has no erythema and eschar formation, no edema, the sensitization rate is 0%, no irritation to the skin, and is effective Avoid eye and skin irritation from functional substances, preservatives and other ingredients, as well as eye and skin discomfort that may occur after long-term use.

(3)本发明的缓解视疲劳的眼部护理组合物,经体外抑菌试验,对金黄色葡萄球菌、大肠杆菌具有明显的抑菌效果,抗菌、防腐效果好;具体表现为眼部护理组合物稀释至50%后,仍具有良好抑菌性能。(3) The eye care composition for relieving visual fatigue of the present invention has obvious antibacterial effect on Staphylococcus aureus and Escherichia coli through in vitro antibacterial test, and has good antibacterial and antiseptic effects; it is specifically expressed as eye care composition After being diluted to 50%, it still has good antibacterial properties.

(4)经试验,本发明的缓解视疲劳的眼部护理组合物,能够有效缓解视疲劳,长时间使用电子产品所导致的眼部的紧绷感、模糊感、疼痛感及疲劳感的缓解效果好,显效率为80-85%,有效率为15-20%。(4) According to tests, the eye care composition for relieving visual fatigue of the present invention can effectively relieve visual fatigue, and relieve eye tension, fuzziness, pain and fatigue caused by long-term use of electronic products The effect is good, the marked rate is 80-85%, and the effective rate is 15-20%.

(5)经试验,本发明的缓解视疲劳的眼部护理组合物,在光照环境下,温度为45℃条件下,静置90天后,无形状变化,未出现分层、析出、沉淀等现象,长期储存稳定性好。(5) According to the test, the eye care composition for relieving visual fatigue of the present invention has no shape change, no delamination, precipitation, precipitation, etc. , good long-term storage stability.

具体实施方式Detailed ways

为了对本发明的技术特征、目的和效果有更加清楚的理解,现说明本发明的具体实施方式。In order to have a clearer understanding of the technical features, purposes and effects of the present invention, specific implementations of the present invention are now described.

实施例1Example 1

一种缓解视疲劳的眼部护理组合物的制备方法,具体为:A preparation method of an eye care composition for alleviating visual fatigue, specifically:

1、预处理1. Pretreatment

将透明质酸钠投入至95倍重量份的去离子水中,分散均匀,降温至2℃,保温静置4h;采用碳酸氢钠-碳酸钠缓冲液调节pH值至8,保持温度为2℃,搅拌20min;然后投入甲基丙烯酸酐,在2℃温度条件下,保温处理10h,获得预处理液;将预处理液投入至3倍体积的无水乙醇中,至无沉淀析出,滤出固体物;固体物采用8倍体积的无水乙醇洗涤后,投入至75倍重量份的去离子水中,搅拌30min,转入至截留分子量为10KDa的透析袋内,采用流动的去离子水进行透析处理20h,制得预处理物。Put sodium hyaluronate into 95 times the weight of deionized water, disperse evenly, cool down to 2°C, and keep it for 4 hours; use sodium bicarbonate-sodium carbonate buffer to adjust the pH value to 8, and keep the temperature at 2°C. Stir for 20 minutes; then put in methacrylic anhydride, heat preservation treatment at 2°C for 10 hours to obtain a pretreatment solution; put the pretreatment solution into 3 times the volume of absolute ethanol until no precipitation occurs, and filter out the solids After the solid matter is washed with 8 times the volume of absolute ethanol, it is dropped into 75 times the weight of deionized water, stirred for 30 minutes, transferred to a dialysis bag with a molecular weight cut-off of 10KDa, and carried out dialysis treatment with flowing deionized water for 20 hours , to obtain a pretreatment.

其中,透明质酸钠与甲基丙烯酸酐的重量份比值为1:2.5。Wherein, the weight ratio of sodium hyaluronate to methacrylic anhydride is 1:2.5.

2、制备活性水凝胶2. Preparation of active hydrogel

将活性成分投入至去离子水中,搅拌20min;然后投入预处理物、N-异丙基丙烯酰胺,继续搅拌20min;在氮气气氛环境下,100rpm搅拌条件下,升温至30℃,投入过硫酸铵,保温搅拌1h,制得活性水凝胶。Put the active ingredient into deionized water and stir for 20 minutes; then put in the pretreated material and N-isopropylacrylamide and continue to stir for 20 minutes; in a nitrogen atmosphere, under the condition of 100rpm stirring, raise the temperature to 30°C, and put in ammonium persulfate , and kept stirring for 1 h to obtain an active hydrogel.

其中,预处理物、N-异丙基丙烯酰胺、活性成分、过硫酸铵、去离子水的重量份比值为30:70:7:0.5:1000。Wherein, the weight ratio of the pretreatment product, N-isopropylacrylamide, active ingredient, ammonium persulfate and deionized water is 30:70:7:0.5:1000.

所述活性成分,按重量份,由以下成分组成:12份罗汉果提取物、8份红薯叶提取物、3份蓝莓提取物。The active ingredient is composed of the following components in parts by weight: 12 parts of Luo Han Guo extract, 8 parts of sweet potato leaf extract, and 3 parts of blueberry extract.

所述罗汉果提取物的规格为80目,提取比例为10:1。The specification of the Luo Han Guo extract is 80 mesh, and the extraction ratio is 10:1.

红薯叶提取物的规格为80目,提取比例为10:1。The specification of sweet potato leaf extract is 80 mesh, and the extraction ratio is 10:1.

蓝莓提取物的规格为80目,提取比例为10:1。The specification of blueberry extract is 80 mesh, and the extraction ratio is 10:1.

3、制备眼部护理组合物3. Preparation of eye care composition

将去离子水升温至85℃,保温20min,自然冷却至常温,投入乙二胺四乙酸二钠、卡波姆、水解胶原蛋白、甘油,分散均匀后,继续投入活性水凝胶、1,2-戊二醇、甘油硬脂酸酯、霍霍巴油、L-丝氨酸、维生素E、生育酚乙酸酯、十八醇,混合均匀,制得缓解视疲劳的眼部护理组合物。Raise the temperature of deionized water to 85°C, keep it warm for 20 minutes, and naturally cool to room temperature, add disodium ethylenediamine tetraacetate, carbomer, hydrolyzed collagen, glycerin, and after dispersing evenly, continue to add active hydrogel, 1,2 - Pentylene glycol, glyceryl stearate, jojoba oil, L-serine, vitamin E, tocopheryl acetate, stearyl alcohol, mixed evenly to prepare an eye care composition for relieving visual fatigue.

其中,去离子水、乙二胺四乙酸二钠、卡波姆、水解胶原蛋白、甘油、活性水凝胶、1,2-戊二醇、甘油硬脂酸酯、霍霍巴油、L-丝氨酸、维生素E、生育酚乙酸酯、十八醇的重量份比值为40:0.15:0.5:2:4:40:6:2:0.8:1.5:0.15:0.05:0.8。Among them, deionized water, edetate disodium, carbomer, hydrolyzed collagen, glycerin, active hydrogel, 1,2-pentanediol, glyceryl stearate, jojoba oil, L-serine , vitamin E, tocopheryl acetate, and stearyl alcohol in parts by weight are 40:0.15:0.5:2:4:40:6:2:0.8:1.5:0.15:0.05:0.8.

实施例2Example 2

一种缓解视疲劳的眼部护理组合物的制备方法,具体为:A preparation method of an eye care composition for alleviating visual fatigue, specifically:

1、预处理1. Pretreatment

将透明质酸钠投入至97倍重量份的去离子水中,分散均匀,降温至3℃,保温静置5h;采用碳酸氢钠-碳酸钠缓冲液调节pH值至8.2,保持温度为3℃,搅拌25min;然后投入甲基丙烯酸酐,在3℃温度条件下,保温处理11h,获得预处理液;将预处理液投入至4倍体积的无水乙醇中,至无沉淀析出,滤出固体物;固体物采用9倍体积的无水乙醇洗涤后,投入至80倍重量份的去离子水中,搅拌40min,转入至截留分子量为11KDa的透析袋内,采用流动的去离子水进行透析处理22h,制得预处理物。Put sodium hyaluronate into 97 times the weight of deionized water, disperse evenly, cool down to 3°C, keep the temperature for 5h; use sodium bicarbonate-sodium carbonate buffer to adjust the pH value to 8.2, keep the temperature at 3°C, Stir for 25 minutes; then put in methacrylic anhydride, heat preservation treatment at 3°C for 11 hours to obtain the pretreatment solution; put the pretreatment solution into 4 times the volume of absolute ethanol until no precipitation occurs, and filter out the solid After the solid matter is washed with 9 times the volume of absolute ethanol, it is dropped into 80 times the weight of deionized water, stirred for 40 minutes, transferred to a dialysis bag with a molecular weight cut-off of 11KDa, and carried out dialysis treatment with flowing deionized water for 22 hours , to obtain a pretreatment.

其中,透明质酸钠与甲基丙烯酸酐的重量份比值为1:2.7。Wherein, the weight ratio of sodium hyaluronate to methacrylic anhydride is 1:2.7.

2、制备活性水凝胶2. Preparation of active hydrogel

将活性成分投入至去离子水中,搅拌30min;然后投入预处理物、N-异丙基丙烯酰胺,继续搅拌25min;在氮气气氛环境下,150rpm搅拌条件下,升温至32℃,投入过硫酸铵,保温搅拌2h,制得活性水凝胶。Put the active ingredient into deionized water and stir for 30 minutes; then put in the pretreated material and N-isopropylacrylamide and continue stirring for 25 minutes; in a nitrogen atmosphere, under the stirring condition of 150rpm, raise the temperature to 32°C, and put in ammonium persulfate , and kept stirring for 2 hours to obtain an active hydrogel.

其中,预处理物、N-异丙基丙烯酰胺、活性成分、过硫酸铵、去离子水的重量份比值为32:73:8:0.55:1100。Wherein, the weight ratio of the pretreatment product, N-isopropylacrylamide, active ingredient, ammonium persulfate and deionized water is 32:73:8:0.55:1100.

所述活性成分,按重量份,由以下成分组成:13份罗汉果提取物、9份红薯叶提取物、4份蓝莓提取物。The active ingredient is composed of the following components in parts by weight: 13 parts of Luo Han Guo extract, 9 parts of sweet potato leaf extract, and 4 parts of blueberry extract.

所述罗汉果提取物的规格为100目,提取比例为20:1。The specification of the Luo Han Guo extract is 100 mesh, and the extraction ratio is 20:1.

红薯叶提取物的规格为100目,提取比例为20:1。The specification of sweet potato leaf extract is 100 mesh, and the extraction ratio is 20:1.

蓝莓提取物的规格为100目,提取比例为20:1。The specification of blueberry extract is 100 mesh, and the extraction ratio is 20:1.

3、制备眼部护理组合物3. Preparation of eye care composition

将去离子水升温至90℃,保温25min,自然冷却至常温,投入乙二胺四乙酸二钠、卡波姆、水解胶原蛋白、甘油,分散均匀后,继续投入活性水凝胶、1,2-戊二醇、甘油硬脂酸酯、霍霍巴油、L-丝氨酸、维生素E、生育酚乙酸酯、十八醇,混合均匀,制得缓解视疲劳的眼部护理组合物。Raise the temperature of deionized water to 90°C, keep it warm for 25 minutes, and naturally cool it to room temperature. Add disodium edetate, carbomer, hydrolyzed collagen, and glycerin. - Pentylene glycol, glyceryl stearate, jojoba oil, L-serine, vitamin E, tocopheryl acetate, stearyl alcohol, mixed evenly to prepare an eye care composition for relieving visual fatigue.

其中,去离子水、乙二胺四乙酸二钠、卡波姆、水解胶原蛋白、甘油、活性水凝胶、1,2-戊二醇、甘油硬脂酸酯、霍霍巴油、L-丝氨酸、维生素E、生育酚乙酸酯、十八醇的重量份比值为42:0.17:0.55:2.5:4.5:42:6.5:2.5:0.9:1.7:0.18:0.055:0.9。Among them, deionized water, edetate disodium, carbomer, hydrolyzed collagen, glycerin, active hydrogel, 1,2-pentanediol, glyceryl stearate, jojoba oil, L-serine , vitamin E, tocopheryl acetate, and stearyl alcohol in parts by weight are 42:0.17:0.55:2.5:4.5:42:6.5:2.5:0.9:1.7:0.18:0.055:0.9.

实施例3Example 3

一种缓解视疲劳的眼部护理组合物的制备方法,具体为:A preparation method of an eye care composition for alleviating visual fatigue, specifically:

1、预处理1. Pretreatment

将透明质酸钠投入至100倍重量份的去离子水中,分散均匀,降温至5℃,保温静置6h;采用碳酸氢钠-碳酸钠缓冲液调节pH值至8.5,保持温度为5℃,搅拌30min;然后投入甲基丙烯酸酐,在5℃温度条件下,保温处理12h,获得预处理液;将预处理液投入至5倍体积的无水乙醇中,至无沉淀析出,滤出固体物;固体物采用10倍体积的无水乙醇洗涤后,投入至85倍重量份的去离子水中,搅拌50min,转入至截留分子量为12KDa的透析袋内,采用流动的去离子水进行透析处理24h,制得预处理物。Put sodium hyaluronate into 100 times the weight of deionized water, disperse evenly, cool down to 5°C, keep it warm for 6h; use sodium bicarbonate-sodium carbonate buffer to adjust the pH value to 8.5, keep the temperature at 5°C, Stir for 30 minutes; then put in methacrylic anhydride, heat preservation treatment at 5°C for 12 hours to obtain the pretreatment solution; put the pretreatment solution into 5 times the volume of absolute ethanol until no precipitation occurs, and filter out the solid After the solid matter is washed with 10 times the volume of absolute ethanol, it is dropped into 85 times the weight of deionized water, stirred for 50 minutes, transferred to a dialysis bag with a molecular weight cut-off of 12KDa, and carried out dialysis treatment with flowing deionized water for 24 hours , to obtain a pretreatment.

其中,透明质酸钠与甲基丙烯酸酐的重量份比值为1:3。Wherein, the weight ratio of sodium hyaluronate to methacrylic anhydride is 1:3.

2、制备活性水凝胶2. Preparation of active hydrogel

将活性成分投入至去离子水中,搅拌40min;然后投入预处理物、N-异丙基丙烯酰胺,继续搅拌30min;在氮气气氛环境下,200rpm搅拌条件下,升温至35℃,投入过硫酸铵,保温搅拌3h,制得活性水凝胶。Put the active ingredient into deionized water and stir for 40 minutes; then put in the pretreated material and N-isopropylacrylamide and continue stirring for 30 minutes; in a nitrogen atmosphere, under the condition of 200rpm stirring, raise the temperature to 35°C, and put in ammonium persulfate , and kept stirring for 3 hours to prepare an active hydrogel.

其中,预处理物、N-异丙基丙烯酰胺、活性成分、过硫酸铵、去离子水的重量份比值为35:75:9:0.6:1200。Wherein, the weight ratio of the pretreatment product, N-isopropylacrylamide, active ingredient, ammonium persulfate and deionized water is 35:75:9:0.6:1200.

所述活性成分,按重量份,由以下成分组成:15份罗汉果提取物、10份红薯叶提取物、5份蓝莓提取物。The active ingredient consists of the following components in parts by weight: 15 parts of Luo Han Guo extract, 10 parts of sweet potato leaf extract, and 5 parts of blueberry extract.

所述罗汉果提取物的规格为90目,提取比例为15:1。The specification of the Luo Han Guo extract is 90 mesh, and the extraction ratio is 15:1.

红薯叶提取物的规格为90目,提取比例为15:1。The specification of sweet potato leaf extract is 90 mesh, and the extraction ratio is 15:1.

蓝莓提取物的规格为90目,提取比例为15:1。The specification of blueberry extract is 90 mesh, and the extraction ratio is 15:1.

3、制备眼部护理组合物3. Preparation of eye care composition

将去离子水升温至90℃,保温25min,自然冷却至常温,投入乙二胺四乙酸二钠、卡波姆、水解胶原蛋白、甘油,分散均匀后,继续投入活性水凝胶、1,2-戊二醇、甘油硬脂酸酯、霍霍巴油、L-丝氨酸、维生素E、生育酚乙酸酯、十八醇,混合均匀,制得缓解视疲劳的眼部护理组合物。Raise the temperature of deionized water to 90°C, keep it warm for 25 minutes, and naturally cool it to room temperature. Add disodium edetate, carbomer, hydrolyzed collagen, and glycerin. - Pentylene glycol, glyceryl stearate, jojoba oil, L-serine, vitamin E, tocopheryl acetate, stearyl alcohol, mixed evenly to prepare an eye care composition for relieving visual fatigue.

其中,去离子水、乙二胺四乙酸二钠、卡波姆、水解胶原蛋白、甘油、活性水凝胶、1,2-戊二醇、甘油硬脂酸酯、霍霍巴油、L-丝氨酸、维生素E、生育酚乙酸酯、十八醇的重量份比值为45:0.2:0.6:3:5:45:7:3:1:2:0.2:0.06:1。Among them, deionized water, edetate disodium, carbomer, hydrolyzed collagen, glycerin, active hydrogel, 1,2-pentanediol, glyceryl stearate, jojoba oil, L-serine , vitamin E, tocopheryl acetate, and stearyl alcohol in parts by weight are 45:0.2:0.6:3:5:45:7:3:1:2:0.2:0.06:1.

对比例1Comparative example 1

采用实施例2的技术方案,其不同在于:省略制备活性水凝胶步骤,并省略活性水凝胶在制备眼部护理组合物步骤中活性水凝胶的添加,并将预处理物、活性成分,直接用于制备眼部护理组合物步骤中。在制备眼部护理组合物步骤中,去离子水、乙二胺四乙酸二钠、卡波姆、水解胶原蛋白、甘油、预处理物、活性成分、1,2-戊二醇、甘油硬脂酸酯、霍霍巴油、L-丝氨酸、维生素E、生育酚乙酸酯、十八醇的重量份比值为71.5:0.17:0.55:2.5:4.5:3:5:6.5:2.5:0.9:1.7:0.18:0.055:0.9。Adopt the technical scheme of embodiment 2, its difference is: omit preparation active hydrogel step, and omit the addition of active hydrogel in the preparation eye care composition step of active hydrogel, and pretreatment thing, active ingredient , directly used in the step of preparing the eye care composition. In the step of preparing the eye care composition, deionized water, disodium edetate, carbomer, hydrolyzed collagen, glycerin, pretreatment, active ingredient, 1,2-pentanediol, glyceryl stearin Ester, jojoba oil, L-serine, vitamin E, tocopheryl acetate, stearyl alcohol ratio in parts by weight are 71.5:0.17:0.55:2.5:4.5:3:5:6.5:2.5:0.9:1.7: 0.18:0.055:0.9.

对实施例1-3、对比例1的缓解视疲劳的眼部护理组合物的皮肤刺激性进行试验,相关试验要求参考国家标准GB/T21608-2008《化学品皮肤致敏试验方法》的相关规定,具体试验方法如下:The skin irritation of the eye care composition for relieving visual fatigue of Examples 1-3 and Comparative Example 1 was tested, and the relevant test requirements refer to the relevant provisions of the national standard GB/T21608-2008 "Chemical Skin Sensitization Test Method" , the specific test method is as follows:

选取100只年龄接近、体重为280-300g的白化豚鼠,其中雄性白化豚鼠50只、雌性白化豚鼠50只。将白化豚鼠随机分为5组,每组20只,且控制组内雄性白化豚鼠和雌性白化豚鼠各半。Select 100 albino guinea pigs of similar age and body weight of 280-300 g, including 50 male albino guinea pigs and 50 female albino guinea pigs. The albino guinea pigs were randomly divided into 5 groups, 20 in each group, and the control group was divided into male albino guinea pigs and female albino guinea pigs.

将1-5组内各白化豚鼠背部两侧的毛发脱除,单侧的毛发脱除面积为3cm*3cm。其中,1-4组对应施用实施例1-3、对比例1的缓解视疲劳的眼部护理组合物,第5组为空白对照组,对应施用去离子水。The hair on both sides of the back of each albino guinea pig in groups 1-5 was removed, and the area of hair removal on one side was 3cm*3cm. Among them, groups 1-4 correspond to the application of the eye care composition for relieving visual fatigue of Examples 1-3 and Comparative Example 1, and group 5 is a blank control group, corresponding to the application of deionized water.

取0.4mL实施例1-3、对比例1的缓解视疲劳的眼部护理组合物及生理盐水,对应涂覆于对应各组的白化豚鼠左侧脱毛区域内,涂覆完成后,在毛发脱除区域表面覆盖两层纱布和一层玻璃纸覆盖,然后采用无刺激胶带密封固定6h;在第7天和第14天时,重复上述操作一次。同时,在第14天时,取0.5mL实施例1-3、对比例1-2的缓解视疲劳的眼部护理组合物及生理盐水,对应涂覆于对应各组的白化豚鼠右侧脱毛区域内,涂覆完成后,在毛发脱除区域表面覆盖两层纱布和一层玻璃纸覆盖,然后采用无刺激胶带密封固定,在第6h、第24h、第48h时,观察皮肤过敏反应情况,并参考GB/T21608-2008中相关规定进行评分。具体试验结果如下:Take 0.4mL of the eye care composition and physiological saline for relieving visual fatigue of Examples 1-3 and Comparative Example 1, and apply them to the left hair removal area of the albino guinea pigs corresponding to each group. The surface of the removed area was covered with two layers of gauze and a layer of cellophane, and then sealed and fixed with non-irritating tape for 6 hours; on the 7th and 14th day, the above operation was repeated once. At the same time, on the 14th day, take 0.5mL of the eye care composition for relieving visual fatigue and physiological saline of Example 1-3 and Comparative Example 1-2, and apply it to the depilatory area on the right side of the albino guinea pig corresponding to each group After the coating is completed, cover the surface of the hair removal area with two layers of gauze and a layer of cellophane, and then seal and fix it with non-irritating tape. At the 6h, 24h, and 48h, observe the skin allergic reaction and refer to GB /T21608-2008 in the relevant regulations for scoring. The specific test results are as follows:

可以看出,实施例1-3的缓解视疲劳的眼部护理组合物对于动物皮肤无致敏性,对比例1的眼部护理组合物出现弱致敏现象,表现为勉强可见的轻微红斑,致敏率为5%。It can be seen that the eye care composition for relieving visual fatigue of Examples 1-3 has no sensitization to animal skin, and the eye care composition of Comparative Example 1 has weak sensitization, showing barely visible slight erythema, The sensitization rate was 5%.

进一步的,对实施例1-3、对比例1的缓解视疲劳的眼部护理组合物进行体外抑菌试验,具体试验方法如下:Further, the eye care composition for alleviating visual fatigue of Examples 1-3 and Comparative Example 1 was subjected to an in vitro antibacterial test, and the specific test methods were as follows:

分别将实施例1-3、对比例1的眼部护理组合物稀释至50%,采用未经稀释的眼部护理组合物、稀释至50%的眼部护理组合物进行体外抑菌作用活性试验;试验用菌为金黄色葡萄球菌、大肠杆菌;具体试验方法参考《消毒技术规范》——2.1.7.3最小抑菌浓度测定试验中的相关内容。具体试验结果如下:The eye care compositions of Examples 1-3 and Comparative Example 1 were diluted to 50% respectively, and the undiluted eye care compositions and the eye care compositions diluted to 50% were used to carry out the antibacterial activity test in vitro The bacteria used in the test are Staphylococcus aureus and Escherichia coli; for the specific test method, refer to the relevant content in "Technical Specifications for Disinfection" - 2.1.7.3 Minimum Inhibitory Concentration Determination Test. The specific test results are as follows:

可以看出,实施例1-3的眼部护理组合物对金黄色葡萄球菌、大肠杆菌、具有明显的抑菌效果,抗菌、防腐效果好;具体表现为眼部护理组合物稀释至50%后,仍具有良好 抑菌性能。It can be seen that the eye care composition of Examples 1-3 has obvious antibacterial effect on Staphylococcus aureus, Escherichia coli, and has good antibacterial and antiseptic effects; it is specifically shown that the eye care composition is diluted to 50%. , still has good antibacterial properties.

进一步的,对实施例1-3、对比例1的缓解视疲劳的眼部护理组合物缓解视疲劳性能进行试验,具体试验方法如下:Further, the eye care composition for relieving visual fatigue of Examples 1-3 and Comparative Example 1 was tested for relieving visual fatigue performance, and the specific test methods were as follows:

选取年龄为20-35岁,视力为300-500度,每日使用电子产品(如电脑等)时长不低于7小时的志愿者80名,控制志愿者男性数量与女性数量均为40名。随机分为4组,并保持各组内男性、女性对半。1-4组分别对应施用实施例1-3、对比例1的缓解视疲劳的眼部护理组合物,施用方法为,清洁脸部后,去绿豆粒大小的眼部护理组合物,均匀涂覆于上眼皮、下眼皮及眼周。每天施用两次,连续施用20天后,调查眼部护理组合物施用效果,并统计相应人数。Select 80 volunteers aged 20-35 years old, with eyesight of 300-500 degrees, and use electronic products (such as computers, etc.) for no less than 7 hours a day. The number of male and female volunteers is 40. They were randomly divided into 4 groups, and each group was kept half male and half female. Groups 1-4 correspond to the application of the eye care compositions of Examples 1-3 and Comparative Example 1 for relieving visual fatigue. The application method is, after cleaning the face, remove the eye care composition of the size of mung bean grains and apply it evenly Apply to upper eyelid, lower eyelid and around the eyes. Apply twice a day, after continuous application for 20 days, investigate the application effect of the eye care composition, and count the corresponding number of people.

其中,关于施用效果的判断,包括以下三类:显效、有效、无效。Among them, the judgment on the application effect includes the following three categories: markedly effective, effective, and ineffective.

显效为,超过2h使用电子产品后,相比于未施用眼部护理组合物前,眼部紧绷感、模糊感、疼痛感及疲劳感同时得到有效的缓解。The significant effect is that after using the electronic product for more than 2 hours, compared with before applying the eye care composition, the sense of tightness, fuzziness, pain and fatigue of the eyes are effectively relieved at the same time.

有效为,超过2h使用电子产品后,相比于未施用眼部护理组合物前,眼部紧绷感、模糊感、疼痛感及疲劳感得到一定程度的缓解。Effectively, after using the electronic product for more than 2 hours, compared with before applying the eye care composition, the eye tightness, blurring, pain and fatigue are relieved to a certain extent.

无效为,相比于未施用眼部护理组合物前,无明显差别。Ineffective means that there is no significant difference compared to before application of the eye care composition.

具体试验结果如下:The specific test results are as follows:

可以看出,实施例1-3的眼部护理组合物能够有效缓解视疲劳,长时间使用电子产品所导致的眼部的紧绷感、模糊感、疼痛感及疲劳感的缓解效果好。It can be seen that the eye care compositions of Examples 1-3 can effectively relieve visual fatigue, and have a good effect on alleviating the tightness, fuzziness, pain and fatigue of the eyes caused by using electronic products for a long time.

进一步的,分别对实施例1-3、对比例1的缓解视疲劳的眼部护理组合物的贮存稳定性进行试验,具体试验方法如下:Further, the storage stability of the eye care composition for relieving asthenopia of Examples 1-3 and Comparative Example 1 was tested respectively, and the specific test methods were as follows:

将试实施例1-3、对比例1的缓解视疲劳的眼部护理组合物置于光照环境下,保持温度为45℃,静置90天后,观察各眼部护理组合物性状是否发生变化,是否出现分层、析出、沉淀等现象。具体试验结果如下:Put the eye care compositions for relieving visual fatigue of Examples 1-3 and Comparative Example 1 under the light environment, keep the temperature at 45°C, and after standing for 90 days, observe whether the properties of each eye care composition change, whether Separation, precipitation, precipitation and other phenomena appear. The specific test results are as follows:

可以看出,本发明实施例1-3的缓解视疲劳的眼部护理组合物,通过采用甲基丙烯酸酐对透明质酸钠进行预处理;并采用预处理物、N-异丙基丙烯酰胺、活性成分用于制备活性水凝胶步骤中;将活性水凝胶与其他特定原料相配合,制得缓解视疲劳的眼部护理组合物,对眼睛刺激性小,无毒副作用,有效避免功能性物质、防腐剂等成分对眼睛的刺激,以及长期使用可能出现的眼睛不适;眼部护理组合物的有效成分易吸收,能够有效缓解视疲劳;并进一步提高眼部护理组合物的长期储存稳定性。It can be seen that the eye care composition for relieving visual fatigue in Examples 1-3 of the present invention uses methacrylic anhydride to pretreat sodium hyaluronate; and uses pretreatment, N-isopropylacrylamide 1. The active ingredient is used in the step of preparing the active hydrogel; the active hydrogel is combined with other specific raw materials to prepare an eye care composition for relieving visual fatigue, which is less irritating to the eyes, has no toxic and side effects, and effectively avoids functional Irritation to the eyes by ingredients such as sexual substances and preservatives, and eye discomfort that may occur after long-term use; the active ingredients of the eye care composition are easy to absorb, and can effectively relieve visual fatigue; and further improve the long-term storage stability of the eye care composition sex.

除非另有说明,本发明中所采用的百分数均为质量百分数。Unless otherwise specified, the percentages used in the present invention are all mass percentages.

最后应说明的是:以上所述仅为本发明的优选实施例而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。Finally, it should be noted that: the above is only a preferred embodiment of the present invention, and is not intended to limit the present invention. Although the present invention has been described in detail with reference to the foregoing embodiments, for those skilled in the art, it still The technical solutions recorded in the foregoing embodiments may be modified, or some technical features thereof may be equivalently replaced. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included within the protection scope of the present invention.

Claims (9)

1. A method for preparing an eye care composition for relieving asthenopia, which is characterized by comprising the following steps: pretreatment, preparation of active hydrogel, preparation of eye care composition;
the pretreatment, namely adding sodium hyaluronate into deionized water, dispersing uniformly, cooling to 2-5 ℃, and keeping the temperature and standing for a certain time; regulating pH value to 8-8.5, maintaining the temperature to 2-5deg.C, and stirring for a certain time; then adding methacrylic anhydride, and carrying out heat preservation treatment for 10-12 hours at the temperature of 2-5 ℃ to obtain pretreatment liquid; adding the pretreatment liquid into absolute ethyl alcohol until no sediment is separated out, and filtering out solid matters; washing the solid with absolute ethyl alcohol, putting the solid into deionized water, stirring uniformly, and dialyzing to obtain a pretreated substance;
the active hydrogel is prepared, active ingredients are put into deionized water and stirred uniformly; then adding the pretreated matter and N-isopropyl acrylamide, and continuously stirring for a certain time; heating to 30-35 ℃ under the stirring condition in a nitrogen atmosphere, adding ammonium persulfate, and stirring for 1-3h under the heat preservation to obtain active hydrogel;
in the preparation of the active hydrogel, the active ingredients consist of the following components: fructus Siraitiae Grosvenorii extract, sweet potato leaf extract, and fructus Myrtilli extract;
the preparation of an eye care composition employs an active hydrogel to prepare an eye care composition.
2. The method for preparing the eye care composition for relieving asthenopia according to claim 1, wherein the eye care composition is prepared by adding disodium ethylenediamine tetraacetate, carbomer, hydrolyzed collagen and glycerin into sterilized deionized water, dispersing uniformly, adding active hydrogel, 1, 2-pentanediol, glycerol stearate, jojoba oil, L-serine, vitamin E, tocopheryl acetate and stearyl alcohol, and mixing uniformly.
3. The method for preparing the eye care composition for relieving asthenopia according to claim 1, wherein in the pretreatment, the weight ratio of sodium hyaluronate to deionized water is 1:95-100;
the weight ratio of the sodium hyaluronate to the methacrylic anhydride is 1:2.5-3.
4. The method for preparing the eye care composition for relieving asthenopia according to claim 1, wherein the molecular weight cut-off during the pretreatment is 10-12kDa and the dialysis treatment time is 20-24h.
5. The method for preparing the eye care composition for relieving asthenopia according to claim 1, wherein the weight ratio of the pretreatment, the N-isopropylacrylamide, the active ingredient, the ammonium persulfate and the deionized water in the preparation of the active hydrogel is 30-35:70-75:7-9:0.5-0.6:1000-1200.
6. The method for preparing the eye care composition for relieving asthenopia according to claim 1, wherein in the preparation of the active hydrogel, the weight ratio of the fructus momordicae extract to the sweet potato leaf extract to the blueberry extract in the active ingredients is 12-15:8-10:3-5.
7. The method for preparing an eye care composition for relieving asthenopia according to claim 1, wherein in the preparation of the active hydrogel, the specification of the momordica grosvenori extract is 80-100 meshes, and the extraction ratio is 10-20:1;
the specification of sweet potato leaf extract is 80-100 meshes, and the extraction ratio is 10-20:1;
the specification of the blueberry extract is 80-100 meshes, and the extraction ratio is 10-20:1.
8. The method for preparing the eye care composition for relieving asthenopia according to claim 2, wherein the weight ratio of deionized water, disodium edetate, carbomer, hydrolyzed collagen, glycerol, active hydrogel, 1, 2-pentanediol, glycerol stearate, jojoba oil, L-serine, vitamin E, tocopheryl acetate, stearyl alcohol is 40-45:0.15-0.2:0.5-0.6:2-3:4-5:40-45:6-7:2-3:0.8-1:1.5-2:0.15-0.2:0.05-0.06:0.8-1 in the eye care composition.
9. An eye care composition for relieving asthenopia, characterized by being prepared by the preparation method of any one of claims 1 to 8.
CN202310401408.9A 2023-04-15 2023-04-15 A kind of eye care composition for alleviating asthenopia and preparation method thereof Withdrawn CN116585219A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310401408.9A CN116585219A (en) 2023-04-15 2023-04-15 A kind of eye care composition for alleviating asthenopia and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310401408.9A CN116585219A (en) 2023-04-15 2023-04-15 A kind of eye care composition for alleviating asthenopia and preparation method thereof

Publications (1)

Publication Number Publication Date
CN116585219A true CN116585219A (en) 2023-08-15

Family

ID=87599736

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310401408.9A Withdrawn CN116585219A (en) 2023-04-15 2023-04-15 A kind of eye care composition for alleviating asthenopia and preparation method thereof

Country Status (1)

Country Link
CN (1) CN116585219A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100039532A (en) * 2008-10-08 2010-04-16 주식회사 제닉 Hydrogel composition for healing atopy and matrix patch for healing atopy using the hydrogel composition as a matrix
CN105106049A (en) * 2015-08-19 2015-12-02 周南燕 Eye care composition and preparation method thereof
WO2017001804A1 (en) * 2015-07-02 2017-01-05 Achaladanelle Cosmetic product made up of two gels forming a film for topical application
CN112674338A (en) * 2020-12-23 2021-04-20 北京博瑞世安科技有限公司 Composition with anti-fatigue effect and preparation method and application thereof
CN113425642A (en) * 2021-07-12 2021-09-24 广州市南方医康生物科技有限公司 Eye care composition for relieving asthenopia and preventing vision deterioration
CN115501321A (en) * 2022-08-26 2022-12-23 朱样根 Multivitamin polypeptide co-carried nano liposome eye protection paste and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100039532A (en) * 2008-10-08 2010-04-16 주식회사 제닉 Hydrogel composition for healing atopy and matrix patch for healing atopy using the hydrogel composition as a matrix
WO2017001804A1 (en) * 2015-07-02 2017-01-05 Achaladanelle Cosmetic product made up of two gels forming a film for topical application
CN105106049A (en) * 2015-08-19 2015-12-02 周南燕 Eye care composition and preparation method thereof
CN112674338A (en) * 2020-12-23 2021-04-20 北京博瑞世安科技有限公司 Composition with anti-fatigue effect and preparation method and application thereof
CN113425642A (en) * 2021-07-12 2021-09-24 广州市南方医康生物科技有限公司 Eye care composition for relieving asthenopia and preventing vision deterioration
CN115501321A (en) * 2022-08-26 2022-12-23 朱样根 Multivitamin polypeptide co-carried nano liposome eye protection paste and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
K. ISHIGURO, M. YOSHIMOTO: "CONTENT OF AN EYE-PROTECTIVE NUTRIENT LUTEIN IN SWEETPOTATO LEAVES", II INTERNATIONAL SYMPOSIUM ON SWEETPOTATO AND CASSAVA: INNOVATIVE TECHNOLOGIES FOR COMMERCIALIZATION, 31 December 2005 (2005-12-31) *
刘建勋: "中药药理学", 31 January 2020, 中国协和医科大学出版社, pages: 327 *
陈先荣,王同德,王海波: "药食同源植物的鉴别与利用", 31 July 2017, 中国农业出版社, pages: 213 *
黄缘麟等: "透明质酸/N-异丙基丙烯酰胺复合水凝胶的制备及其性能", 西南科技大学学报, vol. 36, no. 3, 30 September 2021 (2021-09-30), pages 33 - 40 *

Similar Documents

Publication Publication Date Title
CN107174560B (en) Mild moisturizing and relieving cleansing water and preparation method thereof
CN104434697B (en) Solid floral water that a kind of mosquito-expelling and antipruritic, skin care are calmed the nerves and preparation method thereof
CN108653129B (en) Skin dressing containing natural plant anti-allergy composition
CN104382766A (en) Quick-drying vegetable scar blackening and recovery film
CN112263528A (en) Collagen jelly mask and preparation and use methods thereof
CN109010375B (en) Eye lotion
KR102220534B1 (en) Soothing cream and manufacturing method for the same
CN110755307A (en) Salt lake black mud active mask and preparation method thereof
CN114917155A (en) Centella asiatica-containing composition suitable for repairing sensitive muscles and application thereof
CN112220784B (en) Grape seed hydrolyzed proanthocyanidin eye-protecting liquid for external application and preparation process thereof
CN107519118A (en) A kind of snake gall eye mask and preparation method thereof
CN116585219A (en) A kind of eye care composition for alleviating asthenopia and preparation method thereof
CN106420454A (en) Composition for alleviating dry eyes and visual fatigue, preparation method and application of composition, and roll applicator
CN115154343B (en) Composition and preparation for improving eye relaxation and black eye, preparation method and application
CN105853295A (en) External preparation for child skin mucosa inflammation nursing and application thereof
CN114587767A (en) A kind of cold compress cover, eye cold compress eye patch and preparation process thereof
CN107616953A (en) A kind of anti-acne moisturizing skin care item of the cell extract containing banana figs and preparation method thereof
CN105902686A (en) In-situ gel eyewash containing nano-carbon crystals and preparation method thereof
CN114099551B (en) Asthenopia-relieving and eye-moistening composition
CN114432195A (en) A kind of skin repairing antibacterial composition, gel, application and preparation method
CN110420199A (en) It is a kind of for wound healing and the water gel of cosmetics and its preparation method and application
CN116196345B (en) Composition for improving eye function and application thereof
CN116211984B (en) A Chinese medicinal composition eye ointment for preventing and treating myopia of children and teenagers, and its preparation method
CN111939113A (en) Multi-effect eye muscle activating base solution and preparation method thereof
CN118477122B (en) Chinese medicinal preparation for treating eye diseases by mixed enzyme fermentation and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20230815

WW01 Invention patent application withdrawn after publication